PO-1776 Evaluation of two commercial deep learning OAR segmentation models for prostate cancer treatment. (May 2022) - Gorgisyan, J.; Bengtsson, I.; Lempart, M.; Lerner, M.; Wieslander, E.; Alkner, S.; Jamtheim Gustafsson, C.